Pure Global

INMUNOENSAYO QUIMIOLUMINISCENTE INDIRECTO PARA DETERMINAR ANTICUERPOS IGA, IGG E IGM ESPECÍFICOS FRENTE A CHLAMYDOPHILA PNEUMONIAE - COFEPRIS Registration 1574R2022 SSA

Access comprehensive regulatory information for INMUNOENSAYO QUIMIOLUMINISCENTE INDIRECTO PARA DETERMINAR ANTICUERPOS IGA, IGG E IGM ESPECÍFICOS FRENTE A CHLAMYDOPHILA PNEUMONIAE (INMUNOENSAYO QUIMIOLUMINISCENTE INDIRECTO PARA DETERMINAR ANTICUERPOS IGA, IGG E IGM ESPECÍFICOS FRENTE A CHLAMYDOPHILA PNEUMONIAE) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1574R2022 SSA and manufactured by KABLA COMERCIAL, S.A. DE C.V.. The device was registered on December 14, 2022.

This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

Free Database
Powered by Pure Global AI
COFEPRIS Official Data
Clase I
1574R2022 SSA
INMUNOENSAYO QUIMIOLUMINISCENTE INDIRECTO PARA DETERMINAR ANTICUERPOS IGA, IGG E IGM ESPECÍFICOS FRENTE A CHLAMYDOPHILA PNEUMONIAE
COFEPRIS Analysis ID: 1574R2022 SSA
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Risk Class / Clase de Riesgo
Clase I
Product Type (Spanish)
III. Agentes de diagnóstico
Product Type (English)
III. Agentes de diagnóstico
Trade Name (Spanish)
CHLAMYDOPHILA PNEUMONIAE VIRCLIA® IGA/IGG/IGM MONOTEST
Trade Name (English)
CHLAMYDOPHILA PNEUMONIAE VIRCLIA® IGA/IGG/IGM MONOTEST
Registration Information
Analysis ID
1574R2022 SSA
Registration Date
December 14, 2022
Manufacturer / Fabricante
Name (English)
KABLA COMERCIAL, S.A. DE C.V.